Keyphrases
Atazanavir
100%
Boosted Protease Inhibitors
12%
Darunavir
12%
First-line Therapy
12%
High Protein
12%
HIV Patients
100%
HIV RNA
12%
Inhibitory Quotient
100%
Lopinavir
12%
Nave
100%
Nucleoside Reverse Transcriptase Inhibitors
12%
Once-daily
12%
Pharmacokinetics
100%
Plasma Viral Load
12%
Protease Inhibitors
12%
Protein Binding
100%
Resistance mutations
12%
Resistance Selection
12%
Ritonavir
25%
RNA Copies
12%
Treatment Failure
12%
Trough Level
12%
Virological Failure
12%
Virological Response
25%
Medicine and Dentistry
Atazanavir
100%
Atazanavir Plus Ritonavir
100%
Darunavir
20%
Human Immunodeficiency Virus
100%
Lopinavir
20%
Pharmacokinetics
100%
Protein Binding
100%
Proteinase Inhibitor
40%
Resistance Mutation
20%
Reverse-Transcriptase Inhibitor
20%
Ritonavir
40%
Trough Level
20%
Pharmacology, Toxicology and Pharmaceutical Science
Atazanavir
100%
Atazanavir Plus Ritonavir
100%
Darunavir
20%
HIV
100%
Lopinavir
20%
Pharmacokinetics
100%
Protein Binding
100%
Proteinase Inhibitor
40%
Ritonavir
40%
RNA Directed DNA Polymerase Inhibitor
20%
Trough Level
20%